Saturday, May 18, 2024
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine and Epidemiology
Department of Medicine
Division of Gastroenterology and Hepatology
Director, Center for Esophageal Diseases and Swallowing
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Assistant Professor of Pediatrics
Co-Director of the Gastrointestinal Epithelial Modeling Program, GEM
Associate Director of Fellowship Research
Division of Gastroenterology, Hepatology, and Nutrition
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Medical Director, Asthma
Medical Director, Eosinophilic Gastrointestinal Disorders Clinic
Associate Professor of Pediatrics and Allergy/Immunology
Arkansas Children's Hospital
University of Arkansas for Medical Sciences
Fayetteville, Arkansas
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for gastroenterologists, allergists and clinical immunologists, primary care physicians, pediatricians, and nurses.
The goal of this activity is to improve clinicians’ knowledge and competence regarding assessment of eosinophilic esophagitis (EoE) symptoms and differential diagnosis.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine and Epidemiology
Department of Medicine
Division of Gastroenterology and Hepatology
Director, Center for Esophageal Diseases and Swallowing
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Assistant Professor of Pediatrics
Co-Director of the Gastrointestinal Epithelial Modeling Program, GEM
Associate Director of Fellowship Research
Division of Gastroenterology, Hepatology, and Nutrition
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Medical Director, Asthma
Medical Director, Eosinophilic Gastrointestinal Disorders Clinic
Associate Professor of Pediatrics and Allergy/Immunology
Arkansas Children's Hospital
University of Arkansas for Medical Sciences
Fayetteville, Arkansas
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.50
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 2/18/2022
Valid for credit through: 2/18/2023, 11:59 PM EST
processing....
Before you begin, please take this brief survey.
